scholarly journals Ruthenacarborane and Quinoline: A Promising Combination for the Treatment of Brain Tumors

Molecules ◽  
2021 ◽  
Vol 26 (13) ◽  
pp. 3801
Author(s):  
Dijana Drača ◽  
Milan Marković ◽  
Marta Gozzi ◽  
Sanja Mijatović ◽  
Danijela Maksimović-Ivanić ◽  
...  

Gliomas and glioblastomas are very aggressive forms of brain tumors, prone to the development of a multitude of resistance mechanisms to therapeutic treatments, including cytoprotective autophagy. In this work, we investigated the role and mechanism of action of the combination of a ruthenacarborane derivative with 8-hydroxyquinoline (8-HQ), linked via an ester bond (complex 2), in rat astrocytoma C6 and human glioma U251 cells, in comparison with the two compounds alone, i.e., the free carboxylic acid (complex 1) and 8-HQ, and their non-covalent combination ([1 + 8-HQ], in 1:1 molar ratio). We found that only complex 2 was able to significantly affect cellular viability in glioma U251 cells (IC50 11.4 μM) via inhibition of the autophagic machinery, most likely acting at the early stages of the autophagic cascade. Contrary to 8-HQ alone, complex 2 was also able to impair cellular viability under conditions of glucose deprivation. We thus suggest different mechanisms of action of ruthenacarborane complex 2 than purely organic quinoline-based drugs, making complex 2 a very attractive candidate for evading the known resistances of brain tumors to chloroquine-based therapies.

2017 ◽  
Vol 58 (2) ◽  
pp. 150-159 ◽  
Author(s):  
Lesya I. Коbylinska ◽  
Olga Yu. Klyuchivska ◽  
Iryna I. Grytsyna ◽  
Natalia Finiuk ◽  
Rostyslav R. Panchuk ◽  
...  

2019 ◽  
Vol 21 (Supplement_6) ◽  
pp. vi110-vi110
Author(s):  
Samirkumar Amin ◽  
Kevin Anderson ◽  
Beth Bourdreau ◽  
Emmanuel Martínez ◽  
Emre Kocakavuk ◽  
...  

Abstract Diffuse gliomas are the commonest of malignant brain tumors with high-grade tumors carrying dismal prognosis. Preclinical models have proven themselves as poor predictors of clinical efficacy, attributed to the lack of a comparable tumor microenvironment. Comparative genomics of canine and human gliomas provide an attractive alternative modality to identify conserved drivers and underlying mutational processes of glioma as well as evaluate life history tradeoffs related to tissue context and aging that can shape type and relative timing of drivers in gliomagenesis. We performed a comparative genomics analysis between whole genome-, exome-, transcriptome- and methylation-sequencing of 77 canine gliomas, and human pediatric (n=217) and adult gliomas (n=822). We found alterations in common with those in human pediatric and adult gliomas in the Tp53 and cell cycle pathways, receptor tyrosine kinase and Idh1 R132 mutations. Canine gliomas showed similarity to human pediatric gliomas in terms of lower mutational rates (0.2–0.29 per megabase), hotspot mutations and amplifications of Pdgfrα, and robust aneuploidy constrained within the syntenic regions of Pdgfrα and Myc, but also in the known pediatric drivers, Hist1 and Acvr1 genes. A mutational signature reflecting homologous repair defect was detected in canine and pediatric but not adult gliomas, potentially resulting in the observed higher rates of genomic instability. Canine gliomas in majority classified as pediatric tumors using a commonly used human brain methylation classifier (Capper et al. 2018) and cell-of-origin analysis by deconvoluting canine transcriptome using lineage-specific gene signatures. By providing a large canine glioma genomic-sequencing dataset and comparing it with human glioma, our study provides unique insights into glioma etiology and the chronology of glioma-causing somatic alterations. Further, our results effectively position preclinical models of spontaneous canine glioma for use in understanding glioma drivers, and evaluate novel therapies targeting aneuploidy, especially for pediatric brain tumors.


2015 ◽  
Vol 36 (9) ◽  
pp. 1113-1125 ◽  
Author(s):  
Qing-qing Zhang ◽  
Wen-juan Wang ◽  
Jun Li ◽  
Neng Yang ◽  
Gang Chen ◽  
...  

2014 ◽  
Vol 13 (4) ◽  
pp. 10811-10822 ◽  
Author(s):  
Z.G. Tong ◽  
N. Liu ◽  
H.S. Song ◽  
J.Q. Li ◽  
J. Jiang ◽  
...  

2017 ◽  
Vol 242 (12) ◽  
pp. 1227-1233 ◽  
Author(s):  
Linqian Wang ◽  
Ming Yang ◽  
Shijing Liao ◽  
Wei Liu ◽  
Gan Dai ◽  
...  

Human cytomegalovirus (HCMV) dormant infection can alter the expression of the hosts’ microRNAs (miRNAs) and impact on the regulation of target genes. To investigate the differentially expressed miRNAs induced by HCMV in human glioma U251 cells, a comprehensive miRNA screen was performed. As a result, 19 up-regulated and 14 down-regulated miRNAs were determined. Of these, hsa-miR-27b (miR-27b) attracted our attention. MiR-27b levels in U251 cells increased 7.70-fold, 8.64-fold, and 4.78-fold, respectively, post 24 h, 48 h, and 72 h HCMV infection, compared to those in the mimic-infected cells, and this up-regulation was further confirmed by quantitative RT-PCR. The bioinformatic analyses show that miR-27b targets engrailed-2 (EN2) gene; however, the effect of miR-27b on EN2 is rarely encountered. In this study, we initially conducted dual luciferase assay to validate the target function of miR-27b on EN2. The results manifested that EN2 is a novel target of miR-27b, which could directly target the 3′ untranslated region (3′-UTR) of the gene. We further found that the miR-27b transfected glioma U251 cells exhibited longer cell bodies with more synapses and multiple-angle shapes; moreover, Western blot detection revealed that the EN2 protein levels in these cells were significantly low. In conclusion, our study originally reports the up-regulation of miR-27b in HCMV-infected glioma cells. Our study also provides the first experimental evidence that miR-27b could affect glioma cells’ growth, target EN2 and inhibit its expression in glioma cells. Our data indicate that miR-27b may be related to the development of neurological disorders with HCMV infection. The newly identified miR-27b/EN2 signal pathway may provide new insights into the glioma pathogenesis and a novel target for glioma therapy. Impact statement Our study is the first to demonstrate that the HCMV infection could alter the expression of cellular microRNAs of the host glioma cells, which may develop an understanding of the pathogenesis of the HCMV infection in the microRNA level. Recently, HCMV infection and engrailed-2 have been reported to be related to the autism spectrum disorder (ASD). In this study, we confirmed that engrailed-2 is the target of hsa-miR-27b. As far as we know, our findings of the hsa-miR-27b up-regulation in the HCMV-infected glioma cells, targeting engrailed-2 and inhibiting its expression have never been reported or documented. Our data indicate that miR-27b may be related to the development of neurological disorders with the HCMV infection. The newly identified miR-27b/EN2 signal pathway may provide new insights into the glioma pathogenesis and a novel target for glioma therapy.


Molecules ◽  
2018 ◽  
Vol 23 (5) ◽  
pp. 1072 ◽  
Author(s):  
Li Li ◽  
Yi Yang ◽  
Mingxia Wu ◽  
Zanyang Yu ◽  
Chengqiang Wang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document